These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28186715)

  • 1. Adoption of the Nova Scotia (Canada) Community Pharmacy Medication Management Program, 1-Year Post-Initiation.
    Deal HJ; Cooke CA; Ingram EM; Sketris IS
    J Popul Ther Clin Pharmacol; 2017 Feb; 24(1):e46-e55. PubMed ID: 28186715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between type of drug therapy and blood glucose self-monitoring test strips claimed by beneficiaries of the Seniors' Pharmacare Program in Nova Scotia, Canada.
    Sanyal C; Graham SD; Cooke C; Sketris I; Frail DM; Flowerdew G
    BMC Health Serv Res; 2008 May; 8():111. PubMed ID: 18501012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
    Hirsch JD; Rosenquist A; Best BM; Miller TA; Gilmer TP
    J Manag Care Pharm; 2009; 15(1):32-41. PubMed ID: 19125548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of community pharmacists' recommendations in the North Carolina Medicaid medication therapy management program.
    Michaels NM; Jenkins GF; Pruss DL; Heidrick JE; Ferreri SP
    J Am Pharm Assoc (2003); 2010; 50(3):347-53. PubMed ID: 20452907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Keeping the "continuous" in continuous quality improvement: exploring perceived outcomes of CQI program use in community pharmacy.
    Boyle TA; Bishop AC; Duggan K; Reid C; Mahaffey T; MacKinnon NJ; Mahaffey A
    Res Social Adm Pharm; 2014; 10(1):45-57. PubMed ID: 23528447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacy participation and claim characteristics in the Wisconsin Medicaid Pharmaceutical Care Program from 1996 to 2007.
    Look KA; Mott DA; Leedham RK; Kreling DH; Hermansen-Kobulnicky CJ
    J Manag Care Pharm; 2012 Mar; 18(2):116-28. PubMed ID: 22380471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the Number of Pharmacies a Patient Frequents Affect Adherence to Statins?
    Christie R; Sketris I; Andreou P; Holbrook A; Levy A; Tamim H
    J Popul Ther Clin Pharmacol; 2017 May; 24(2):e20-e50. PubMed ID: 28594479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of deinsuring chlorpropamide on the prescribing of oral antihyperglycemics for Nova Scotia Seniors' Pharmacare beneficiaries.
    Sketris IS; Kephart GC; Frail DM; Skedgel C; Allen MJ
    Pharmacotherapy; 2004 Jun; 24(6):784-91. PubMed ID: 15222669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in pharmacy prescription refill adherence measures by type of oral antihyperglycaemic drug therapy in seniors in Nova Scotia, Canada.
    Morningstar BA; Sketris IS; Kephart GC; Sclar DA
    J Clin Pharm Ther; 2002 Jun; 27(3):213-20. PubMed ID: 12081636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in the medication reviews of community pharmacies in Japan: a nationwide retrospective study.
    Koyama T; Onoue H; Ohshima A; Tanaka Y; Tatebe Y; Zamami Y; Shinomiya K; Kitamura Y
    Int J Clin Pharm; 2018 Feb; 40(1):101-108. PubMed ID: 29189975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a limited fluoroquinolone reimbursement policy on antimicrobial prescription claims.
    MacCara ME; Sketris IS; Comeau DG; Weerasinghe SD
    Ann Pharmacother; 2001; 35(7-8):852-8. PubMed ID: 11485132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacy characteristics associated with the provision of medication management services within an integrated care management program.
    Smith MG; Shea CM; Brown P; Wines K; Farley JF; Ferreri SP
    J Am Pharm Assoc (2003); 2017; 57(2):217-221.e1. PubMed ID: 28173992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Descriptive analysis of pharmacy services provided after community pharmacy screening.
    Lancaster K; Thabane L; Tarride JE; Agarwal G; Healey JS; Sandhu R; Dolovich L
    Int J Clin Pharm; 2018 Dec; 40(6):1577-1586. PubMed ID: 30474769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient care activities by community pharmacists in a capitation funding model mental health and addictions program.
    Murphy AL; Gardner DM; Jacobs LM
    BMC Psychiatry; 2018 Jun; 18(1):192. PubMed ID: 29898682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of a reimbursed medication review program: Corporate and pharmacy level strategies.
    MacKeigan LD; Ijaz N; Bojarski EA; Dolovich L
    Res Social Adm Pharm; 2017; 13(5):947-958. PubMed ID: 28462792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of wet nebulized inhaled respiratory medications under criteria-based reimbursement guidelines in a publicly funded Seniors' Pharmacare Program in Nova Scotia, Canada.
    Bowles SK; Sketris I; Kephart G;
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):120-8. PubMed ID: 17719514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing an integrated care management program in community pharmacies: A focus on medication management services.
    Smith MG; Ferreri SP; Brown P; Wines K; Shea CM; Pfeiffenberger TM
    J Am Pharm Assoc (2003); 2017; 57(2):229-235.e1. PubMed ID: 28173993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of a Student Pharmacist-Run Targeted Medication Intervention Program.
    Melody KT; Shah CJ; Patel J; Willey VJ
    J Pharm Pract; 2017 Feb; 30(1):109-114. PubMed ID: 26072428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying the use of the statin antilipemic drugs: comparisons and contrasts between Nova Scotia, Canada, and Queensland, Australia.
    Cooke C; Nissen L; Sketris I; Tett SE
    Clin Ther; 2005 Apr; 27(4):497-508. PubMed ID: 15922822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of a medication therapy management collaborative within a pediatric health system.
    Sneed G; Kappeler K; Gilmore T; Kuhn C
    J Am Pharm Assoc (2003); 2018; 58(4S):S114-S119. PubMed ID: 29871801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.